You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Androgen-Resistant Prostatic Neoplasms

Showing 26 - 50 of 8,157
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Trial in United States (Darolutamide, Enzalutamide)

Recruiting
  • Metastatic Prostate Cancer
  • +3 more
  • San Diego, California
  • +11 more
Nov 28, 2022

Prostate Cancer Metastatic Trial in Leiden (Enzalutamide, 18-FDG PET/CT, Whole body MRI)

Completed
  • Prostate Cancer Metastatic
  • Leiden, Netherlands
    Leiden University Medical Center
Apr 6, 2022

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory

Active, not recruiting
Has Results
  • Castration Levels of Testosterone
  • +9 more
  • Recombinant EphB4-HSA Fusion Protein
  • Los Angeles, California
  • +2 more
Apr 4, 2022

Prostate Cancer Trial in Ann Arbor, Detroit (ARRx, Enzalutamide)

Suspended
  • Prostate Cancer
  • Ann Arbor, Michigan
  • +1 more
Dec 17, 2021

Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated

Recruiting
  • Prostate Cancer
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 27, 2021

Castration-resistant Prostate Cancer Trial in Osaka (Enzalutamide, Flutamide)

Completed
  • Castration-resistant Prostate Cancer
  • Osaka, Japan
    Osaka City University Graduate School of Medicine
Sep 8, 2021

Prostate Cancer Trial in Baltimore (18F-DCFPyL Injection)

Withdrawn
  • Prostate Cancer
  • 18F-DCFPyL Injection
  • Baltimore, Maryland
    Johns Hopkins University
Dec 14, 2021

Metastatic Prostate Cancer Trial in Guangzhou (Metformin)

Not yet recruiting
  • Metastatic Prostate Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Jun 11, 2021

Castration-Resistant Prostatic Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in United States (GnRH

Recruiting
  • Castration-Resistant Prostatic Cancer
  • +4 more
  • GnRH agonist/antagonist
  • +3 more
  • Los Angeles, California
  • +3 more
Apr 30, 2021

Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Acapatamab, Enzalutamide, Abiraterone)

Active, not recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Birmingham, Alabama
  • +13 more
Jun 20, 2022

Non-metastatic Castration-resistant Prostate Cancer Trial in India (Darolutamide (Nubeqa, BAY1841788))

Not yet recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Darolutamide (Nubeqa, BAY1841788)
  • Hyderabad, Andhra Pradesh, India
  • +22 more
Jul 29, 2022

Castration-resistant Prostate Cancer, Androgen Deprivation Therapy Trial in Chapel Hill, Winston-Salem (Home-based exercise)

Completed
Has Results
  • Castration-resistant Prostate Cancer
  • Androgen Deprivation Therapy
  • Home-based exercise
  • Chapel Hill, North Carolina
  • +1 more
Mar 26, 2021

Prostate Cancer Trial in Boston, Brooklyn, New York (225Ac-J591, Pembrolizumab, Androgen receptor pathway inhibitor)

Recruiting
  • Prostate Cancer
  • Boston, Massachusetts
  • +3 more
Sep 20, 2021

Prostatic Tumors Trial in China (Apalutamide, Placebo, Androgen-deprivation Therapy (ADT))

Recruiting
  • Prostatic Neoplasms
  • Beijing, China
  • +29 more
Aug 15, 2022

Efficacy After Anti-androgen Therapy for CRPC

Active, not recruiting
  • Castration Resistant Prostate Cancer (CRPC)
    • (no location specified)
    Jan 5, 2021

    Prostate Cancer, Malignant Tumor of Prostate, Secondary Malignant Tumor of Prostate Trial in Cleveland (drug, other, radiation)

    Not yet recruiting
    • Prostate Cancer
    • +2 more
    • Androgen deprivation therapy (ADT)
    • +3 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center Seidman Cancer Cen
    Nov 21, 2023

    Metastatic Castrate-resistant Prostate Cancer, Adenocarcinoma, Prostate Trial in United States (TRC253)

    Completed
    Has Results
    • Metastatic Castrate-resistant Prostate Cancer
    • Adenocarcinoma, Prostate
    • Birmingham, Alabama
    • +4 more
    Mar 29, 2021

    Castration-Resistant Prostatic Cancer Trial ([Lu-177]-PNT2002)

    Available
    • Castration-Resistant Prostatic Cancer
    • (no location specified)
    Sep 11, 2023

    Metastatic Castration-resistant Prostate Cancer Trial (ONCT-534)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • (no location specified)
    Jun 15, 2023

    Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)

    Active, not recruiting
    • Prostate Cancer
    • Abiraterone Acetate
    • +3 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 6, 2022

    Prostatic Adenocarcinoma Trial in Seoul (Enzalutamide)

    Not yet recruiting
    • Prostatic Adenocarcinoma
    • Seoul, Korea, Korea, Republic of
      Samsung Medical Center
    Aug 23, 2023

    Prostatic Tumors, Castration-Resistant Trial in New York (TVB-2640, Enzalutamide)

    Not yet recruiting
    • Prostatic Neoplasms, Castration-Resistant
    • New York, New York
      Weill Cornell Medicine/NewYork-Presbyterian Hospital
    Feb 23, 2023

    Prostatic Tumors, Castration-Resistant Trial in Darlinghurst, Pretoria (225^Ac-PSMA-617, 68^Ga-PSMA-11)

    Recruiting
    • Prostatic Neoplasms, Castration-Resistant
    • 225^Ac-PSMA-617
    • 68^Ga-PSMA-11
    • Darlinghurst, Australia
    • +1 more
    Nov 23, 2022

    Prostate Cancer Trial (iMAB, cMAB)

    Not yet recruiting
    • Prostate Cancer
    • (no location specified)
    Jul 26, 2023

    Prostatic Tumors, Castration-Resistant Trial in Brisbane ([212Pb]Pb-ADVC001)

    Not yet recruiting
    • Prostatic Neoplasms
    • Castration-Resistant
    • Brisbane, Queensland, Australia
      Royal Brisbane & Women's Hospital
    Feb 9, 2023